1. Home
  2. ROCK vs NTLA Comparison

ROCK vs NTLA Comparison

Compare ROCK & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gibraltar Industries Inc.

ROCK

Gibraltar Industries Inc.

HOLD

Current Price

$50.47

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$9.58

Market Cap

986.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROCK
NTLA
Founded
1972
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
986.9M
IPO Year
1993
2016

Fundamental Metrics

Financial Performance
Metric
ROCK
NTLA
Price
$50.47
$9.58
Analyst Decision
Buy
Analyst Count
0
22
Target Price
N/A
$19.83
AVG Volume (30 Days)
286.3K
3.6M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$1,383,811,000.00
$57,528,000.00
Revenue This Year
N/A
$1.96
Revenue Next Year
$6.98
N/A
P/E Ratio
$11.20
N/A
Revenue Growth
23.49
33.52
52 Week Low
$42.86
$5.90
52 Week High
$75.08
$28.25

Technical Indicators

Market Signals
Indicator
ROCK
NTLA
Relative Strength Index (RSI) 44.23 47.26
Support Level $48.76 $8.74
Resistance Level $51.96 $9.85
Average True Range (ATR) 1.52 0.47
MACD 0.40 0.30
Stochastic Oscillator 41.83 70.25

Price Performance

Historical Comparison
ROCK
NTLA

About ROCK Gibraltar Industries Inc.

Gibraltar Industries Inc manufactures and provides products and services for the Renewable energy, Residential, Agtech, and Infrastructure markets. The Renewables Segment is engaged in designing, engineering, manufacturing, and installing solar racking and electrical balance systems. Agtech Segment provides growing and processing solutions including the designing, engineering, manufacturing, full-scope construction, maintenance, and support of greenhouses and indoor growing operations, and botanical extraction systems. It derives key revenue from the Residential segment which offers roof and foundation ventilation products, single point and centralized mail systems electronic package solutions, and Retractable awnings and gutter guards, among other products.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: